tenofovir

Also found in: Medical, Wikipedia.

te·nof·o·vir

 (tə-nŏf′ə-vîr)
n.
An antiviral drug, C9H14N5O4P, used in the form of a prodrug (tenofovir disoproxil fumarate) to treat chronic hepatitis B and, in combination with other drugs, to treat HIV infection or to reduce the risk of HIV infection.
[teno-, of unknown origin + fo- (alteration of pho(spho)-) + (anti)vir(al).]
American Heritage® Dictionary of the English Language, Fifth Edition. Copyright © 2016 by Houghton Mifflin Harcourt Publishing Company. Published by Houghton Mifflin Harcourt Publishing Company. All rights reserved.
Translations

tenofovir

n tenofovir m
English-Spanish/Spanish-English Medical Dictionary Copyright © 2006 by The McGraw-Hill Companies, Inc. All rights reserved.
Mentioned in
References in periodicals archive
The product is the company's fourth tenofovir alafenamide-based therapy.
Ontario Drug Benefit Program to offer eligible HIV patients access to Gilead Sciences Canada's Biktarvy tablets
THURSDAY, July 25, 2019 (HealthDay News) -- Tenofovir preexposure prophylaxis (PrEP) therapy does not appear to be associated with clinically significant declines in bone mineral density (BMD) in the short term, according to a study published online June 19 in AIDS Research and Human Retroviruses.
Minor Changes in BMD Seen With Tenofovir PrEP in Short Term; Those at high risk for fracture who plan prolonged PrEP use may wish to consider alternative strategies
Spring Bank also announces the expansion of a collaborative study in patients infected with chronic HBV involving the evaluation of multiple doses of inarigivir co-administered with tenofovir alafenamide 25mg to include the 400mg dose of inarigivir.
Spring Bank Pharmaceuticals announceds dosing of inarigivir in HBV studies
Tenofovir disoproxil fumarate (TDF) is a prodrug of tenofovir diphosphate, a structural analog of deoxyadenosine triphosphate, which is the natural substrate for the viral enzyme reverse transcriptase.
Prevalence of Nephrotoxicity in HIV Patients Treated with Tenofovir Disoproxil Fumarate: A Single-center Observational Study
Biopharmaceutical company Gilead Sciences Inc reported on Monday the availability of Vemlidy (tenofovir alafenamide, TAF) in 25 mg for the once-daily treatment of adults with chronic hepatitis B with compensated liver disease upon approval from Taiwan National Health Insurance Administration of the Ministry of Health and Welfare.
Gilead Sciences Inc unveils Vemlidy in 25 mg for the once-daily treatment of adults with chronic hepatitis B
Tenofovir disoproksil fumarat (TDF) hepatit B ve HIV infeksiyonu tedavisinde kullanilan nukleotid ad- enin analogudur.
A Rare Side Effect That May Be Due to Tenofovir Disoproxil Fumarate: Nail Pitting/ Tenofovir Disoproksil Fumarata Bagli Olabilecek Nadir Bir Yan Etki: Yuksuk Tirnak
Patients between 18 and 70 years receiving oral antiviral agents (lamivudine, entecavir, or tenofovir disproxil fumarate) for a minimum duration of 3 years due to CHB were included.
Assessment of histopathological alterations in patients with chronic hepatitis B infection following long-term oral antiviral therapy
The patent and licensing status of entecavir and tenofovir, two WHO-recommended medicines for HBV treatment, were examined using the Medicines Patent Pool MedsPaL ([dagger]) database.
Access to Treatment for Hepatitis B Virus Infection--Worldwide, 2016
Food and Drug Administration in 2001 has prompted considerable interest in studying the incidence and severity of tenofovir nephrotoxicity.
ACUTE KIDNEY INJURY AND CHRONIC KIDNEY DISEASE IN HIV PATIENTS IN THE ERA OF ANTIRETROVIRAL THERAPY
This study sought to assess the comparative immune reconstitution potential between tenofovir and zidovudine-based HAART regimens, which includes lamivudine and efavirenz in combination therapy It also aimed to investigate the adverse drug reactions/events (ADREs) associated with pharmacotherapy with these agents in a total of 106 HAART naive HIV patients.
Tenofovir-Based Highly Active Antiretroviral Therapy Is Associated with Superior CD4 T Cells Repopulation Compared to Zidovudine-Based HAART in HIV 1 Infected Adults
Background: Tenofovir disoproxil (TDF) is a promising salvage therapy for patients with chronic hepatitis B (CHB) who failed regimens of other nucleoside analogues (NAs).
Efficacy and Safety of Tenofovir Disoproxil Treatment for Chronic Hepatitis B Patients with Genotypic Resistance to Other Nucleoside Analogues: A Prospective Study
Copyright © 2003-2025 Farlex, Inc Disclaimer
All content on this website, including dictionary, thesaurus, literature, geography, and other reference data is for informational purposes only. This information should not be considered complete, up to date, and is not intended to be used in place of a visit, consultation, or advice of a legal, medical, or any other professional.